Literature DB >> 33663066

Herbal medicine for behavioral and psychological symptoms of dementia: A protocol for systematic review.

Chan-Young Kwon1, Boram Lee2, Da-Jung Ha3.   

Abstract

BACKGROUND: Dementia is becoming a major public health problem worldwide with the aging of the world's population. Behavioral and psychological symptoms of dementia (BPSD), associated symptoms of dementia, not only predicts the poor prognosis of patients with dementia, but is also a major factor causing the care burden on caregivers, especially informal caregivers. For BPSD management, an alternative to existing psychotropic drugs is needed, given the benefit-harm ratio. Therefore, in this systematic review, we will evaluate the effectiveness and safety of herbal medicine for BPSD. METHODS AND ANALYSIS: Thirteen electronic databases will be comprehensively searched. Clinical studies reporting the efficacy (or effectiveness) and safety of herbal medicines in BSPD management published from their inception to December 2020 will be included. The primary outcome will be BPSD symptoms assessed by the validated tool. Moreover, total effective rate, daily living activities and quality of life of patients, burden and quality of life of caregiver, placement in a long-term care facility from home, and safety data will be regarded as the secondary outcome. Two independent researchers will perform the study selection, data extraction, and quality assessment process. To assess the methodological quality of the included studies, validated tools according to its design, such as the Cochrane Collaboration's risk of bias tool will be used. To perform meta-analysis, RevMan version 5.3 will be used, with mean differences for continuous outcomes and risk ratio for binary outcomes, and 95% confidence intervals. According to the heterogeneity and number of included studies, a fixed- or random-effects model will be used. REGISTRATION NUMBER: OSF (URL: https://osf.io/3u8ch), PROSPERO (CRD42020211000) (URL: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42020211000).
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33663066      PMCID: PMC7909178          DOI: 10.1097/MD.0000000000024577

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  30 in total

1.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX.

Authors:  F I MAHONEY; D W BARTHEL
Journal:  Md State Med J       Date:  1965-02

Review 2.  Effect of Chinese Herbal Medicine on Alzheimer's Disease.

Authors:  Melanie-Jayne R Howes; Rui Fang; Peter J Houghton
Journal:  Int Rev Neurobiol       Date:  2017-03-24       Impact factor: 3.230

Review 3.  Prevalence of psychiatric disorders among older adults in long-term care homes: a systematic review.

Authors:  Dallas Seitz; Nitin Purandare; David Conn
Journal:  Int Psychogeriatr       Date:  2010-06-04       Impact factor: 3.878

4.  Psychotropic medications and risk for falls among community-dwelling frail older people: an observational study.

Authors:  Francesco Landi; Graziano Onder; Matteo Cesari; Christian Barillaro; Andrea Russo; Roberto Bernabei
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-05       Impact factor: 6.053

5.  The Bayer Activities of Daily Living Scale (B-ADL).

Authors:  I Hindmarch; H Lehfeld; P de Jongh; H Erzigkeit
Journal:  Dement Geriatr Cogn Disord       Date:  1998       Impact factor: 2.959

6.  The quality of life in late-stage dementia (QUALID) scale.

Authors:  M F Weiner; K Martin-Cook; D A Svetlik; K Saine; B Foster; C S Fontaine
Journal:  J Am Med Dir Assoc       Date:  2000 May-Jun       Impact factor: 4.669

7.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.

Authors:  Larissa Shamseer; David Moher; Mike Clarke; Davina Ghersi; Alessandro Liberati; Mark Petticrew; Paul Shekelle; Lesley A Stewart
Journal:  BMJ       Date:  2015-01-02

8.  ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.

Authors:  Jonathan Ac Sterne; Miguel A Hernán; Barnaby C Reeves; Jelena Savović; Nancy D Berkman; Meera Viswanathan; David Henry; Douglas G Altman; Mohammed T Ansari; Isabelle Boutron; James R Carpenter; An-Wen Chan; Rachel Churchill; Jonathan J Deeks; Asbjørn Hróbjartsson; Jamie Kirkham; Peter Jüni; Yoon K Loke; Theresa D Pigott; Craig R Ramsay; Deborah Regidor; Hannah R Rothstein; Lakhbir Sandhu; Pasqualina L Santaguida; Holger J Schünemann; Beverly Shea; Ian Shrier; Peter Tugwell; Lucy Turner; Jeffrey C Valentine; Hugh Waddington; Elizabeth Waters; George A Wells; Penny F Whiting; Julian Pt Higgins
Journal:  BMJ       Date:  2016-10-12

9.  Dementia treatment versus prevention.

Authors:  Robert Perneczky
Journal:  Dialogues Clin Neurosci       Date:  2019-03       Impact factor: 5.986

10.  The worldwide costs of dementia 2015 and comparisons with 2010.

Authors:  Anders Wimo; Maëlenn Guerchet; Gemma-Claire Ali; Yu-Tzu Wu; A Matthew Prina; Bengt Winblad; Linus Jönsson; Zhaorui Liu; Martin Prince
Journal:  Alzheimers Dement       Date:  2016-08-29       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.